Dexametasone

Phase 3Small molecule

Dexametasone is one of 89 small molecule programs targeting DLBCL - Diffuse Large B Cell Lymphoma. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

DLBCL - Diffuse Large B Cell LymphomaRecruiting

InfluenzaNot yet recruiting

Post Operative PainCompleted

DLBCL - Diffuse Large B Cell LymphomaPhase 3

Recruiting

InfluenzaPhase 3

Not yet recruiting

Post Operative PainPreclinical

Completed

Competition

Competitive Landscape

95 competitors in Influenza

#DrugCompanyPhaseTrials

Influenza Vaccine

Novartis

Phase 3

71 2

FLU Vaccine

GSK

Phase 3

8 3

Inactivated Influenza Vaccine

Sanofi

Phase 3

14 4

Lagevrio

Merck & Co.

Phase 2

2 5

Seasonal Influenza Vaccine

Novartis

Phase 3

22 6

Live Attenuated Zoster Vaccine

CChangchun BCHT Biotechnology Co.

Phase 3

12 7

Avigan

AAppili Therapeutics Inc.

Phase 2

6 8

Relenza

GGlaxo Dba Glaxosmithkline

Phase 3

5 9

VAXIGRIP

GSK

Phase 3

8 10

Dexametasone

UUniversity of Malaya

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 3Recruiting

DLBCL - Diffuse Large B Cell Lymphoma

NCT07739654

Q4 2029

Phase 3Not yet recruiting

Influenza

NCT07786662

Clinical

Trials by Indication[1]

Recurrent Laryngeal Nerve1 trial

Intra-operative Steroid Irrigation for Reducing Recurrent Laryngeal Nerve Palsy Post-thyroidectomy

Enrolling by invitation·UUniversity of Malaya·N/A·NCT07068048·100 enrolled

Post Operative Pain1 trial

The Effect of Dexamethasone in Full Pulpotomy on Postoperative Pain in Permanent Molars

Completed·—·N/A·NCT07233577·72 enrolled

Perioperative Pain1 trial

Oxycodone Extended-release in the Treatment of Perioperative Pain in Patients Undergoing Orthopaedic Surgery

Completed·HHospital Central Dr. Luis Ortega·Phase 4·NCT02238340·40 enrolled

Acute Lymphoblastic Leukemia1 trial

Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

Completed·PPETHEMA Foundation·Phase 4·NCT02036489·107 enrolled

Influenza1 trial

Early Corticosteroids in Severe Influenza Pneumonia, a Phase III Randomized Controlled Trial

Not yet recruiting·CCentre Hospitalier Régional Metz-Thionville·Phase 3·NCT07786662·544 enrolled

1 more indication

DLBCL - Diffuse Large B Cell Lymphoma1 trial

Comparison of Effectiveness and Toxicities of Modified DHAP Protocol With Standard DHAP Protocol in Patients With Relapsed/Refractory Diffused Large B-cell Lymphoma.

Recruiting·KKing Edward Medical University·Phase 3·NCT07739654·74 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Dexametasone. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Dexametasone compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Dexametasone. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Malaya company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of Malaya

Dexametasone

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q4 2029

Trials by Indication[1]

Recurrent Laryngeal Nerve1 trial

Post Operative Pain1 trial

Perioperative Pain1 trial

Acute Lymphoblastic Leukemia1 trial

Influenza1 trial

DLBCL - Diffuse Large B Cell Lymphoma1 trial

References

Drug Info

Quick Facts

Related News